You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx

Article metrics

Article menu
Download PDFPDF
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx

 

Online download statistics by month:

Online download statistics by month: March 2016 to March 2024

AbstractFullPdf
Mar 2016210
Apr 2016011
May 2016501
Jun 2016001
Jul 2016300
Sep 2016200
Jan 2017100
Mar 2017101
Apr 2017100
May 2017100
Jun 2017300
Jul 2017200
Aug 2017400
Oct 2017201
Jan 2018200
Mar 2018600
May 2018200
Jul 2018200
Aug 2018200
Oct 2018200
Dec 2018100
Jan 2019200
Feb 2019400
Apr 2019400
Jun 2019200
Jul 2019401
Aug 2019200
Apr 2020200
Jun 2020400
Jul 2020801
Aug 2020201
Sep 20201000
Oct 2020200
Jan 20211003
Feb 2021201
Apr 2021201
May 2021201
Jun 2021002
Jul 2021002
Aug 2021004
Sep 2021003
Oct 20214013
Nov 20213011
Dec 2021403
Jan 2022200
Feb 2022201
Mar 2022002
Apr 2022200
May 2022705
Jun 2022202
Jul 2022401
Aug 20221401
Sep 2022408
Oct 2022404
Nov 2022601
Dec 2022400
Jan 2023604
Feb 2023200
Mar 2023600
Apr 2023400
May 2023002
Jul 2023603
Aug 2023002
Sep 2023001
Oct 2023600
Nov 2023603
Dec 20233000
Jan 20241200
Feb 2024600
Mar 2024600
Total258292